Cell, tissue and gene therapies – Regulatory challenges and responses in Australia | Hogan Lovells
Australian regulation of cell, tissue, and gene therapies (CTGT) is relatively new, with the regulatory framework for biological medical products first being introduced in 2011. A...
National One Stop Shop Office Of The Gene Technology Regulator Advisory Committee Tissue Regulatory Framework Stakeholder Perspective Clinical Trial Approval
Source: jdsupra.com